Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism Disorders

Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.

3,312 public trials 328 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism Disorders trial results

Completed

A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients.

NCT00708370

Conditions
Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
Locations
  • Pfizer Investigational Site Jitra, Kubang Pasu, Kedah, Malaysia
  • Pfizer Investigational Site Kulim, Kedah, Malaysia
  • Pfizer Investigational Site Sik, Kedah, Malaysia
  • Pfizer Investigational Site Kubang Kerian, Kelantan, Malaysia
View all 22 locations
View Trial Details
Completed

Comparative Atorvastatin Pleiotropic Effects

NCT00163202

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +12 more
Locations
  • Pfizer Investigational Site Calgary, Alberta, Canada
  • Pfizer Investigational Site Edmonton, Alberta, Canada
  • Pfizer Investigational Site Vancouver, British Columbia, Canada
  • Pfizer Investigational Site Winnipeg, Manitoba, Canada
View all 74 locations
View Trial Details
Completed

Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia

NCT00141141

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Pfizer Investigational Site S. Benedetto DEL Tronto, Ascoli Piceno, Italy
  • Pfizer Investigational Site S.Pietro Vernotico, Brindisi, Italy
  • Pfizer Investigational Site Casarano, Lecce, Italy
  • Pfizer Investigational Site Pavia, PV, Italy
View all 35 locations
View Trial Details
Completed

A Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High Cholesterol

NCT00645424

Conditions
Dyslipidemias, Hyperlipidemias, Lipid Metabolism Disorders, +2 more
Locations
  • Pfizer Investigational Site Kaohsiung City, Taiwan
  • Pfizer Investigational Site Kaohsiung Hsien, Taiwan
  • Pfizer Investigational Site Taichung, Taiwan
  • Pfizer Investigational Site Taipei, Taiwan
View Trial Details
Completed

Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets

NCT00442325

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Brain Diseases, +23 more
Locations
  • Pfizer Investigational Site Ioannina, Greece
  • Pfizer Investigational Site Kallithea, Athens, Greece
  • Pfizer Investigational Site Pireaus, Greece
  • Pfizer Investigational Site Thessaloniki, Greece
View all 32 locations
View Trial Details

Related conditions